Our previous studies in xenograft models of MM, another B-cell malignancy, were also conducted in SCID-Beige mice and indicate that the mechanism of antitumor activity of our ch128.1 antibodies (both IgG1 and IgG3) is dependent on the Fc region of the antibodies. The gene discussed is IGHG3; the disease is Miyoshi myopathy.